Total Visits

Views
Immunohistochemical biomarkers are prognostic relevant in addition to the ESMO-ESGO-ESTRO risk classification in endometrial cancer99

Total Visits Per Month

April 2022May 2022June 2022July 2022August 2022September 2022October 2022
Immunohistochemical biomarkers are prognostic relevant in addition to the ESMO-ESGO-ESTRO risk classification in endometrial cancer7387811

File Visits

Views
gynonc_a2021v161p787.pdf69

Top country views

Views
United States43
China9
Spain7
Ireland2
Russia2
United Kingdom1
Sweden1
Slovenia1

Top cities views

Views
Secaucus16
Woodbridge6
Cambridge5
Fairfield5
Fuzhou2
Houston2
Wilmington2
Ann Arbor1
Beijing1
Garden City1